Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells.
about
Linking form to function: Biophysical aspects of artificial antigen presenting cell designCombining radiotherapy and cancer immunotherapy: a paradigm shiftMolecular mimics of the tumour antigen MUC1Cancer immunotherapy: how low-level ionizing radiation can play a key role.Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.Mechanisms and applications of interleukins in cancer immunotherapy.T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion.Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response.Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine-induced killer cells.T-cell exhaustion in the tumor microenvironment.Effects of CIK on hypoxia inducible factor-1α and T-cell subsets on colon 26 cancer xenograft mice.Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3(+) regulatory T cells and are associated with poor prognosis in breast cancer patients.Enterobacteriaceae bacteremias among cancer patients: an observational cohort studyImmune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy.Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammationTwist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells.A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapyEnrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation.Stressful presentations: mild cold stress in laboratory mice influences phenotype of dendritic cells in naïve and tumor-bearing mice.Shaping of NK cell responses by the tumor microenvironmentThe mechanism of action of BCG therapy for bladder cancer--a current perspective.Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.PD-L1-specific T cells.Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.Dendritic cells in bone marrow at diagnosis and after chemotherapy in adult patients with acute myeloid leukaemia.Immunosuppressive mechanisms of regulatory dendritic cells in cancer.Dendritic cells in the cancer microenvironment.Spontaneous presence of FOXO3-specific T cells in cancer patients.Integrated Nanovaccine with MicroRNA-148a Inhibition Reprograms Tumor-Associated Dendritic Cells by Modulating miR-148a/DNMT1/SOCS1 Axis.Skin Allografting Activates Anti-tumor Immunity and Suppresses Growth of Colon Cancer in Mice.
P2860
Q27002652-6C04E38E-E576-4D0A-8E41-873C10FB0DA6Q27021428-5D89B501-D279-4BBD-A86F-CD16D594B466Q28485169-62F7E540-C44F-4E96-A51B-1F18F0489D6CQ30235014-BDCBAFA5-6CC3-4514-B0B6-5DD0136D9813Q34216061-DFC7172B-EA02-4964-BF66-BD08B3D330CFQ34458290-DF77E4C7-B2E5-402D-98A4-25ABFC7ABB05Q35594838-D013C5AA-97C6-4B8C-9A28-5177D91E729DQ35798899-E8C48594-3DE3-4C08-A5CB-26E6D0C936DDQ35799198-66F63981-955E-42F6-8BB0-D6F8CA348CD5Q35879402-DF2E6711-90A5-4316-8CA0-5A0A394A1694Q36347369-2DB9DB69-A652-4666-B974-93F211FFC6F4Q36524871-75C5EEFE-F6B4-4F5A-BCB9-EBED533D47A8Q36643627-12565A98-70FD-4780-99A0-8AF2AB89C80FQ36785151-6AA4DDB7-68EF-45FD-BC87-2ECF130CD14AQ36813010-F6EC5A35-F513-48B4-8C4A-4B016C1697CEQ37259195-6E40A2EA-6B80-4DC3-A365-C8183F964008Q37291308-74B11023-9BD2-4562-89F8-D6D7EC4F7016Q37366098-9E973449-B95B-4DB3-AB3A-5787A9E708EAQ37370230-6CA391FB-8841-4F0D-8A00-78DD0940A628Q37482548-1DB35ACF-69BC-4ED3-8B26-61326D12F645Q37571842-5FE13CE8-EF82-476C-8C6E-88A809041B06Q38067641-7AF8FFDD-158B-434D-AC34-6AA827A5B81DQ38184849-08B09E97-E032-4F11-8530-F161CC1929DCQ38336989-3F0DB205-9A04-44F0-BA11-DF1C6D14D91EQ38685359-70350FED-B03A-4F69-B47D-0A58026D1E17Q39858290-1886CA46-2A8F-4433-8E4B-0EC147988E7DQ41688469-F6BB6CEF-538B-4A68-B882-ED0E62754523Q43084328-39E11104-7F2A-48CB-8DFD-39724579787FQ43163888-3F11FC1F-A873-4C94-93CA-771D6C6CD1DFQ43196241-88045E60-1A75-4D67-8A09-19605F6612F4Q51639107-A5A281B5-3822-4485-954D-09778B20E998Q55717021-637EB1A5-2B62-4EC9-8578-F8A710DFCB6E
P2860
Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune suppression in the tumo ...... iated tolerization of T cells.
@en
Immune suppression in the tumo ...... iated tolerization of T cells.
@nl
type
label
Immune suppression in the tumo ...... iated tolerization of T cells.
@en
Immune suppression in the tumo ...... iated tolerization of T cells.
@nl
prefLabel
Immune suppression in the tumo ...... iated tolerization of T cells.
@en
Immune suppression in the tumo ...... iated tolerization of T cells.
@nl
P2860
P1476
Immune suppression in the tumo ...... diated tolerization of T cells
@en
P2093
Arthur A Hurwitz
Stephanie K Watkins
P2860
P2888
P304
P356
10.1007/S00262-011-1181-5
P577
2012-01-12T00:00:00Z